Josamycin: International drug information (concise)
For abbreviations, symbols, and age group definitions used in Lexicomp (
show table)
International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AE) United Arab Emirates: Josacine;
-
(AT) Austria: Josalid;
-
(BG) Bulgaria: Wilprafen;
-
(CH) Switzerland: Josacin;
-
(CN) China: Josamy;
-
(CO) Colombia: Scherimicina;
-
(CZ) Czech Republic: Wilprafen;
-
(DO) Dominican Republic: Josalid;
-
(EE) Estonia: Wilprafen;
-
(ES) Spain: Josamina;
-
(FR) France: Josacine;
-
(HU) Hungary: Wilprafen;
-
(ID) Indonesia: Josaxin;
-
(IT) Italy: Iosalide;
-
(JO) Jordan: Josalid;
-
(LB) Lebanon: Josacine;
-
(LT) Lithuania: Josalid | Josamina | Wilprafen;
-
(LU) Luxembourg: Josacine;
-
(LV) Latvia: Josamina | Wilprafen;
-
(MA) Morocco: Josacine;
-
(PH) Philippines: Yamanouchi josamycin;
-
(PL) Poland: Josamina;
-
(RU) Russian Federation: Wilprafen;
-
(SA) Saudi Arabia: Josaxin;
-
(TN) Tunisia: Josacine;
-
(UA) Ukraine: Wilprafen
Reported Use
Treatment of infections caused by susceptible organisms including infections of the upper and lower respiratory system
Dosage Range
Adults: Oral: 1-2 g every 24 hours in 2-3 divided doses
Product Availability
Product available in various countries; not currently available in the US
Dosage Forms
Suspension, oral: 125 mg/5 mL, 250 mg/5 mL, 375 mg/5 mL
Tablet: 500 mg, 750 mg, 1000 mg
Topic 10400 Version 49.0
